Core aspects and embodiments of the Lectenz® development platform are the subject of a pending patent application (Glycan-Specific Analytical Tools) assigned jointly to the University of Georgia Research Foundation (UGARF) and the company.  The company is actively building an intellectual property portfolio to maximize freedom to operate. Patents associated with the company’s technologies include:

  • Glycan-Specific Analytical Tools. PCT Application PCT/US2009/67582.
  • Glycoprofiling with Multiplexed Suspension Arrays. PCT Application PCT/US2012/027211.
  • Glycomimetics to Inhibit Pathogen-Host Interactions. U.S. Patent Number 9,605,014.
  • Carbohydrate-Binding Polypeptide. PCT Application PCT/US2015/026374.
  • Sialic Acid Binding Polypeptide.

Additional Lectenz®-specific patent applications are expected to be filed as novel Lectenz® reagents, are engineered and characterized. These Lectenz® reagents will be included in the GlycoSenseTM kits. A federally registered trademark for Lectenz® was issued in 2009. Trade secrets protect certain elements of the process for producing GlycoSenseTM kits and Lectenz® reagents, including knowledge gained through in silico and in vitro experimentation.